Upstream Bio, Inc. · NASDAQ:UPB
Xiangmin Cui reported a 6.10% stake in Upstream Bio, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
Xiangmin Cui reported a 6.10% stake in Upstream Bio, Inc., 3,285,293 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 6.10%
- Shares
- 3,285,293
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | 5.80% | 3,085,293 |
| Decheng Capital Management IV (Cayman), LLC | 5.80% | 3,085,293 |
| Decheng Capital Global Healthcare Fund (Master), LP | 0.40% | 200,000 |
| Decheng Capital Global Healthcare GP, LLC | 0.40% | 200,000 |
| Xiangmin Cui | 6.10% | 3,285,293 |
Source
Related
- Upstream Bio, Inc.
- Decheng Capital Global Life Sciences Fund IV, L.P.
- Upstream Bio, Inc. shareholders
- Schedule 13G/A · Decheng Capital Global Life Sciences Fund IV, L.P. · May 15, 2026
- Form 4 · Deykin Aaron · Sep 17, 2026
- Form 4 · Sutherland Everett Rand · Sep 17, 2026
- Form 4 · Houghton Adam · Sep 17, 2026
- Form 4 · Gray Michael · Sep 17, 2026
- Form 4 · Ambrose Allison · Sep 17, 2026